Fulvestrant (F)+Placebo vs F+Palbociclib First Line for Postmenopausal Hormone Receptor+ Advanced Breast Cancer

Clinical trial NCT02690480 · UNKNOWN

Trial details

NCT number: NCT02690480
Sponsor: Spanish Breast Cancer Research Group
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Breast Neoplasms

Start date: 2016-02-17
Primary completion: 2020-01-11
Enrollment: 189

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.